Intellectual Property In India: Novartis Gleevec Patent Battle Will Go On Without Government Document Supporting “Evergreening” (Part 1 of 3)

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".